China Nuokang Bio-Pharma , Nasdaq: NKBP
Leading provider of blood-clotting medication in China.
Industry: Health Care
First Day Return: -3.7%
NKBP
Leading provider of blood-clotting medication in China.
| IPO Data | |
|---|---|
| IPO Date | 12/09/2009 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $45 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Shenyang, Liaoning Province, China |
| Founded | 1997 |
| Employees at IPO | n/a |
| Website www.nkbp.com | |
IPO News for China Nuokang Bio-Pharma
China Nuokang Bio-Pharma (NKBP) Performance
